March 2, 2017 / 12:23 PM / 6 months ago

BRIEF-Cipher Pharmaceuticals Q4 net loss $11.3 million

March 2 (Reuters) - Cipher Pharmaceuticals Inc

* Cipher Pharmaceuticals reports 2016 Q4 & year-end financial results

* Cipher Pharmaceuticals Inc qtrly total revenue of $10.7 million, an increase of 10% from $9.7 million in Q4 2015

* Cipher Pharmaceuticals Inc qtrly net loss of $11.3 million, or $0.45 per basic share

* Cipher Pharmaceuticals Inc says "we continue to pursue strategic options for U.S. business"

* Cipher Pharmaceuticals says have taken steps to reduce cost structure; expect to achieve cash savings of about $3 million on annualized basis Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below